nathalie Lassau
机构: Professor at Gustave Roussy University Paris Saclay
每年引用次数
引用次数
引用: 18,573
H-指数: 59
I10-指数 : 151
出版物: 454
Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments.
Nathalie Lassau , Baya Benatsou , Mohamed Chebil , Alain Roche
Discovery Medicine 11 ( 56) 18 -24
67
2011
Quelle imagerie pour les thérapies ciblées
Nathalie Lassau , Baya Benatsou , Mohamed Chebil , Alain Roche
Bulletin Du Cancer 95 ( 10) 989 -993
1
2008
Imagerie des mélanomes : performances de l’échographie sans et avec injection de produit de contraste pour le diagnostic et l’évaluation des traitements
Nathalie Lassau , Pierre Peronneau , Linda Chami
Bulletin Du Cancer 94 ( 1) 93 -98
16
2007
Imagerie et angiogenèse : la DCE-US (dynamic contrast enhanced-ultrasonography)
Nathalie Lassau , Alain Roche
Bulletin Du Cancer 94 ( 5) 247 -253
2007
Intérêt de l’échographie‐Doppler pour évaluer l’efficacité d’un traitement anti‐angiogénique par thalidomide dans le cancer du rein métastatique
Nathalie Lassau , Jérome Leclère , Bernard Escudier , Sophie Bidault
Bulletin Du Cancer 91 ( 7) 629 -635
10
2004
[Current events about echography in 2006: position of the ultrasound functional imaging for the early evaluation of targeted therapeutics].
Nathalie Lassau , Pierre Péronneau , Linda Chami
Bulletin Du Cancer 93 ( 12) 1207 -1211
4
2006
Study of tumor perfusion parameters obtained using dynamic contrast enhanced ultrasonography (DCE-US) in a phase I trial of patients treated with sorafenib and dacarbazine
Nathalie Lassau , Baya Benatsou , Christophe Massard , Jean-Pierre Armand
Molecular Cancer Therapeutics 6
2007
Apport de l'échographie avec produit de contraste
Nathalie Lassau
e-VEGF-IMMUNO-actu 4 ( 4) 2 -5
2009
Demonstration in animal and human of AVE8062-induced tumor blood flow shutdown using dynamic contrast enhanced-ultrasonography (DCE-US).
Nathalie Lassau , Chantal Carrez , Brigitte Demers , Marie-Christine Bissery
Cancer Research 67
3
2007
Molecular Magnetic Resonance and Ultrasound Imaging of Tumor Angiogenesis
Nathalie Lassau , Marie Poirier-Quinot , Xavier Violas , Stéphanie Pitre-Champagnat
International Journal of Radiology and Imaging Technology 3
2017
Hyperprogressive disease during immunotherapy: an attempt to clarify different definitions
Nathalie Lassau , Benjamin Besse , Hugues Talbot , Caroline Caramella
2019
Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients.
Nathalie Lassau , Samy Ammari , Emilie Chouzenoux , Hugo Gortais
Nature Communications 12 ( 1) 634 -634
110
2021
Influence of Magnetic Field Strength on Magnetic Resonance Imaging Radiomics Features in Brain Imaging, an In Vitro and In Vivo Study.
Nathalie Lassau , Stephanie Pitre-Champagnat , Samy Ammari , Corinne Balleyguier
Frontiers in Oncology 10 541663 -541663
19
2021
Comorbidity and frailty assessment in renal cell carcinoma patients.
Nathalie Lassau , Nathalie Lassau , Alexandre De La Taille , Alexandre Ingels
World Journal of Urology 1 -11
2021
Contrast-enhanced brain MRI synthesis with deep learning: key input modalities and asymptotic performance
Nathalie Lassau , Samy Ammari , Corinne Balleyguier , Émilie Chouzenoux
international symposium on biomedical imaging 1159 -1163
13
2021
Imaging: towards a global solution to overcome the cancer pandemic.
Nathalie Lassau , Corinne Balleyguier , Isabelle Borget , Fabrice Barlesi
Lancet Oncology 22 ( 4) 430 -432
2021
Correction to: Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers.
Nathalie Lassau , Marius E Mayerhoefer , Marius E Mayerhoefer , Ronald Boellaard
European Radiology 1 -12
35
2021
Lightweight U-Net for Lesion Segmentation in Ultrasound Images
Nathalie Lassau , Baya Benatsou , Emilie Chouzenoux , Benoit Charmettant
international symposium on biomedical imaging 611 -615
2021
Automatic cervical lymphadenopathy segmentation from CT data using deep learning.
Nathalie Lassau , Nathalie Lassau , Nicolas Gogin , François Bidault
Diagnostic and interventional imaging
2021
Ziv-aflibercept (A) combined to FOLFIRI as first line treatment for metastatic colorectal cancer (mCRC): Interim safety and efficacy results of the phase II PULSAR trial.
Antoine Adenis , Francois Ghiringhelli , Jean Luc Raoul , Emmanuelle Tresch
Journal of Clinical Oncology 35 737 -737
2017